文献速递分子诊断临床免疫

从QuantiFERON-TB金管中提取DNA用于PCR和测序的方案

Protocol for DNA extraction from QuantiFERON-TB gold tubes for PCR and sequencing applications.
PubMed 文献 · Clin Chim Acta · 2026-10-23

本研究开发了一种从QuantiFERON-TB金管全血中直接提取高质量DNA的混合裂解联合三种商业试剂盒的方法,并与EDTA管提取的DNA进行比较。结果显示两种来源的DNA在浓度、纯度及PCR和全外显子组测序应用中无差异,A260/280为1.7-1.9,浓度4.9-118.5 μg/mL,测序Q20>98.6%,Q30>95%。该方案无需额外采血即可将LTBI免疫诊断与下游分子分析整合。

要点

  • QFT管血可直接提取DNA用于PCR和测序,无需额外采血。
  • EDTA与QFT管DNA在产量、纯度及下游应用中无差异。
  • 提取DNA浓度4.9-118.5 μg/mL,A260/280为1.7-1.9,完整性良好。

核心结论

  • 从QFT管血中提取的DNA适用于PCR和测序,为LTBI诊断与基因组研究整合提供经济实用方案。

研究设计与样本

  • 方法学研究,采用手动裂解联合Thermo Scientific GeneJET、QIAamp DNA Blood Kit和FavorPrep™ Blood Genomic DNA Extraction Kit三种商业试剂盒从EDTA管和QFT管血中提取DNA。

主要发现

  • EDTA管与QFT管提取DNA在 quantity、quality 及PCR或测序应用上无差异。
  • 提取DNA的A260/280比值为1.7-1.9,浓度范围为4.9-118.5 μg/mL。
  • 琼脂糖凝胶电泳显示基因组DNA完整且PCR产物条带清晰。
  • 全外显子组测序每样本产出6.47-8.71 GB数据,42.8-57.7 M reads,GC含量49.29%-52.54%。
  • 测序质量指标Q20值超过98.6%,Q30值高于95%。

临床怎么用

  • 可利用QFT管残留血样进行下游PCR和测序,无需额外采血,尤其适合资源有限环境。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Latent tuberculosis infection (LTBI) remains a significant barrier to global TB control and elimination efforts. The QuantiFERON-TB Gold (QFT) assay is commonly used for the diagnosis of LTBI. However, blood collected in QFT tubes is seldom utilized for molecular and genetic analysis due to the presence of heparin and a dense gel barrier that hinders efficient DNA extraction. To address this limitation, we aimed to develop a method for directly isolating high-quality DNA from blood in QFT tubes, eliminating the need for additional blood sampling and enabling their use in both diagnostic and molecular workflows. In this study, DNA was extracted from blood in EDTA and QFT tubes using a hybrid approach that combined manual lysis with three commercial kits: Thermo Scientific GeneJET, QIAamp DNA Blood Kit, and FavorPrep™ Blood Genomic DNA Extraction Kit. DNA concentration and purity were measured with a Multiskan SkyHigh Microplate Spectrophotometer, while integrity was assessed through agarose gel electrophoresis. Two nucleic acid amplification techniques (NAATs), ARMS-PCR and whole exome sequencing (WES) were performed to validate applicability of extracted DNA for molecular biology applications. We did not find any differences in the quantity, quality, or application of PCR or sequencing for DNA extracted from EDTA or QFT tubes. The extracted DNA from both EDTA and QFT tubes exhibited A260/280 ratios of 1.7-1.9 and concentrations ranging from 4.9 to 118.5 μg/mL, indicating an adequate yield and purity. Intact genomic DNA and PCR product bands on agarose gel indicated suitability for downstream applications. Additionally, WES produced 6.47-8.71 GB of data per sample, with 42.8-57.7 M reads and GC content between 49.29% and 52.54%. Sequencing metrics were consistently strong, with Q20 values exceeding 98.6% and Q30 values above 95%. Our study presents an optimized and reproducible protocol for DNA extraction suitable for downstream PCR and sequencing technologies. This protocol provides economical and practical strategy to integrate LTBI diagnosis with genomic research, particularly beneficial in resource-limited settings. This study introduces a novel analytical workflow applicable to diagnostic laboratory settings, enabling the integration of routine LTBI immunodiagnostic testing with downstream genomic analysis. The approach supports improved utilization of clinical specimens in laboratory medicine and may facilitate future biomarker and precision diagnostics research.

来源:Clin Chim Acta,查看原文。版权归原作者所有。

引用

  1. Subhan U, Akram Z, Shafqat S, et al. Protocol for DNA extraction from QuantiFERON-TB gold tubes for PCR and sequencing applications. Clin Chim Acta. 2026. PMID: 42918590. doi:10.1016/j.cca.2026.122943

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。